October 30, 2017
RegMed Investors’ (RMi) pre-open indications; don’t get agitated
October 27, 2017
RegMed Investors’ (RMi) pre-open indications; headwinds remain
October 26, 2017
RegMed Investors’ (RMi) pre-open indications; oversold
October 25, 2017
RegMed Investors’ (RMi) pre-open indications; we need to escape the ravages of the downside
October 24, 2017
RegMed Investors’ (RMi) pre-open indications; every company has another side
October 23, 2017
RegMed Investors’ (RMi) pre-open indications; the glass half empty
October 20, 2017
RegMed Investors’ (RMi) pre-open indications; price resilience in a bad market is a positive
October 19, 2017
RegMed Investors’ (RMi) pre-open indications; lot of challenges
October 18, 2017
RegMed Investors’ (RMi) pre-open indications; after many busts in the sector, there has to be a little boom
October 17, 2017
RegMed Investors’ (RMi) pre-open indications; the battle of the oversold versus the overbought
October 16, 2017
RegMed Investors’ (RMi) pre-open indications; what we need to know for today
October 13, 2017
RegMed Investors’ (RMi) pre-open indications; the oversold are undervalued in more ways than one
October 12, 2017
RegMed Investors’ (RMi) pre-open indications; the turning of the herd
October 11, 2017
RegMed Investors’ (RMi) pre-open indications; the big squeeze
October 10, 2017
RegMed Investors’ (RMi) pre-open indications; when is enough downside, enough and a whipsaw in the making?
October 9, 2017
RegMed Investors’ (RMi) pre-open indications; what are the dynamics in cell therapy investing?
October 6, 2017
RegMed Investors’ (RMi) pre-open indications; the butterfly effect
October 5, 2017
RegMed Investors’ (RMi) pre-open indications; what news are we waiting to hear?
October 4, 2017
RegMed Investors’ (RMi) pre-open indications; correlation not causation
October 3, 2017
RegMed Investors’ (RMi) pre-open indications; tread lightly
October 2, 2017
RegMed Investors’ (RMi) pre-open indications; focusing on the path forward
September 29, 2017
RegMed Investors’ (RMi) pre-open indications; last session of the month and quarter
September 28, 2017
RegMed Investors’ (RMi) pre-open indications; sector equities are punching above their weight class
September 27, 2017
RegMed Investors’ (RMi) pre-open indications; the sector is spooked
September 26, 2017
RegMed Investors’ (RMi) pre-open indications; the sector optic isn’t that good but …
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.